Mechanisms of Dupilumab in AERD

Clinical trial NCT05031455 · COMPLETED

Trial details

NCT number: NCT05031455
Sponsor: Scripps Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Aspirin-exacerbated Respiratory Disease

Start date: 2024-03-25
Primary completion: 2026-04-20
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.